« Back to Record
Citation APA

Lonez, C., Verma, B., Hendlisz, A., Aftimos, P., Awada, A., Van Den Neste, E., Catala, G., Machiels, J. P. J., Piette, F., Brayer, J. J., Sallman, D. D., Kerre, T., Odunsi, K., Davila, M. M., Gilham, D., & Lehmann, F. (2017). Study protocol for THINK: A multinational open-label phase i study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour types. BMJ open, 7(11), e017075. doi:10.1136/bmjopen-2017-017075


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/279757

Lonez, C., Verma, B., Hendlisz, A., Aftimos, P., Awada, A., Van Den Neste, E., Catala, G., Machiels, J. P. J., Piette, F., Brayer, J. J., Sallman, D. D., Kerre, T., Odunsi, K., Davila, M. M., Gilham, D., & Lehmann, F. (2017). Study protocol for THINK: A multinational open-label phase i study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour types. BMJ open, 7(11), e017075. doi:10.1136/bmjopen-2017-017075